Nicole Seguy, ICEID 2022: Hepatitis B and C: Elimination as a public health goal

An estimated 354 million people worldwide live with hepatitis B or C, and for most, testing and treatment remain beyond reach. Consequently, the World Health Organization (WHO) has set the goal of eliminating hepatitis B and C by 2030. Dr Nicole Seguy (Regional Advisor HIV, hepatitis and STIs, WHO/Europe) summarizes the existing landscape of hepatitis B and C in a global context and discusses the interventions and advances that will help to achieve this goal.

‘Hepatitis B and C: Elimination as a Public Health Goal’ was presented at the annual International Conference on Emerging Infectious Diseases (ICEID), August 7–10, 2022. 

Questions:

1. Could you give us a brief overview of the global health burden of hepatitis B and C? (00:14)
   
2. What elimination goals have been set by the WHO? (00:41)
3. What interventions in terms of prevention and testing can help meet this goal? (01:18)
4. What therapeutic advances have helped make elimination feasible? (02:08)
5. What barriers exist to meeting this goal and how may they be overcome? (02:52)

Disclosures: Nicole Seguy has nothing to disclose in relation to this video interview. 

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Marianna Mignani. 

Filmed as a highlight of ICEID 2022.